🇺🇸 FDA
Patent

US 11142505

Compositions for APP-selective BACE inhibition and uses therefor

granted A61PA61P25/28

Quick answer

US patent 11142505 (Compositions for APP-selective BACE inhibition and uses therefor) held by The Regents of the University of California expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P25/28